Share on facebook
Share on twitter
Share on linkedin

April, 2016: BioAegis Therapeutics Wins Best Presentation Award at the CM-Equity Conference

BOSTON, MA and MORRISTOWN, NJ, (BIOAEGIS THERAPEUTICS) April 22, 2016 BioAegis Therapeutics Inc., a privately held biotechnology company commercializing plasma gelsolin (pGSN) won Best Presentation Award at the CM-Equity Conference in Munich, Germany.  Presenting for the company was Mr. Steven Cordovano, Co-Founder and Vice President of Investor Relations.

CM-Equity is a diversified financial services firm in Munich, Germany with a wide ranging customer base that includes institutional investors, family offices and fund managers.

Read the full press release here: CM-Equity Cfx 2016